Intrinsiq Research, Inc.

IntrinsiQ, LLC is the market leader in information management for the cancer care market. IntrinsiQ is a fast-growing, privately held company located in Waltham, Massachusetts, in the heart of Boston s Rt. 128 technology corridor. The company is focused entirely on the cancer care market, the second largest market in healthcare. IntrinsiQ has established unique, innovative technology platforms that are significantly impacting many aspects of the continuum of care in cancer. The Company s proprietary IntelliDose technology is the leading software product for automating the chemotherapy dose calculation process. IntelliDose is used in a rapidly growing list of over 100 oncology practices, including some of the most prestigious cancer centers in the US. In addition to its benefits as a clinical tool, IntelliDose is also the premier means for gathering detailed data about the use of drugs in the cancer care process. IntrinsiQ collects data from a panel of its users who provide rights to the data that the system collects. Under this arrangement, IntrinsiQ collects a wide range of longitudinal clinical information and can conduct multiple strategic analyses of any disease across a large number of physicians, patients, and protocols. In addition, IntelliDose enables the filtering of data for previously unavailable analysis related to disease, pathology, stage, patient demographics, and use of pharmaceuticals...